Surface Oncology and Merck to Collaborate on Immuno-Oncology Study Evaluating SRF617, Targeting CD39 in Combination with KEYTRUDA® (pembrolizumab) in Solid Tumor Patients
May 20, 2020 07:05 ET
|
Surface Oncology, Inc.
CAMBRIDGE, Mass., May 20, 2020 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor...
ISG Future Workplace Summit to Examine All Aspects of Work in Digital Age
February 10, 2020 10:00 ET
|
Information Services Group, Inc.
STAMFORD, Conn., Feb. 10, 2020 (GLOBE NEWSWIRE) -- Leveraging digital technology to reimagine the workplace and the workforce of the future will be the focus of the ISG Future Workplace Summit,...
Merck Grant to Support Smithsonian Future Exhibition on History of American Medicine
September 03, 2019 10:08 ET
|
Smithsonian's National Museum of American History
Washington, D.C., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Merck recently awarded a $500,000 grant to the Smithsonian’s National Museum of American History to use for developing an exhibition and...
Cocrystal Pharma Reports Second Quarter 2019 Financial Results and Provides Corporate Update
August 09, 2019 08:05 ET
|
Cocrystal Pharma, Inc.
– Company continues to drive clinical and research programs forward to achieve multiple value-driving milestones– – Business development initiative underway with active discussions ongoing to secure...
VERSUM MATERIALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
May 21, 2019 18:15 ET
|
Rigrodsky & Long, P.A.
WILMINGTON, Del., May 21, 2019 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A.: Do you own shares of Versum Materials, Inc. (NYSE: VSM)?Did you purchase any of your shares prior to April 12, 2019?Do...
OpGen and Merck’s ILÚM Health Solutions to Host Event at VIII International Symposium on Hospital Acquired Infections and Antimicrobial Stewardship
March 25, 2019 07:30 ET
|
OpGen, Inc.
GAITHERSBURG, Md., March 25, 2019 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN) announced today it will host an event with ILÚM Health Solutions, LLC (“ILÚM”), a wholly owned subsidiary of Merck’s...
Cocrystal Pharma Announces Exclusive Worldwide License and Collaboration Agreement with Merck
January 03, 2019 08:30 ET
|
Cocrystal Pharma, Inc.
BOTHELL, WA, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel...
Real Endpoints Appoints Jeff Berkowitz, CEO and Director
September 13, 2018 11:14 ET
|
Real Endpoints
MADISON, N.J., Sept. 13, 2018 (GLOBE NEWSWIRE) -- Real Endpoints (RE), a leader in the development and implementation of proprietary tools to strengthen pharmaceutical market access for an evolving...
MerckInvents@ TEC Edmonton Accepting Applications
January 16, 2018 12:00 ET
|
TEC Edmonton
EDMONTON, Alberta, Jan. 16, 2018 (GLOBE NEWSWIRE) -- Recruitment is now open for MerckInvents@ TEC Edmonton, a new health technology accelerator and partnership between TEC Edmonton, Merck Canada...
Agile Therapeutics to Present at the Rodman & Renshaw 19th Annual Global Investment Conference
August 22, 2017 07:30 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Aug. 22, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women’s health specialty pharmaceutical company, announced today that Al Altomari, Chairman and CEO will...